RYOIX Holdings Information

RYOIX is a mutual fund with a total of 72 individual holdings. The top holdings are AbbVie stock at 8.47%, Amgen at 5.58%, Gilead Sciences at 4.81%, Vertex Pharmaceuticals at 4.31%, and Regeneron Pharmaceuticals at 3.73%.

Total Holdings

Top 10 Percentage

38.68%

Asset Class

Equity

Fund Category

Health

Assets

131.59M

Forward PE Ratio

n/a

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	ABBV	AbbVie Inc.	8.47%	41,857
2	AMGN	Amgen Inc.	5.58%	17,967
3	GILD	Gilead Sciences, Inc.	4.81%	45,852
4	VRTX	Vertex Pharmaceuticals Incorporated	4.31%	11,212
5	REGN	Regeneron Pharmaceuticals, Inc.	3.73%	6,062
6	RVMD	Revolution Medicines, Inc.	2.58%	17,066
7	ONC	BeOne Medicines AG	2.50%	9,826
8	ILMN	Illumina, Inc.	2.35%	14,191
9	RPRX	Royalty Pharma plc	2.18%	46,268
10	NTRA	Natera, Inc.	2.17%	10,057
11	BIIB	Biogen Inc.	2.08%	12,690
12	GH	Guardant Health, Inc.	1.93%	14,768
13	VTRS	Viatris Inc.	1.78%	126,044
14	INCY	Incyte Corporation	1.77%	18,394
15	MRNA	Moderna, Inc.	1.75%	39,559
16	INSM	Insmed Incorporated	1.72%	21,673
17	UTHR	United Therapeutics Corporation	1.71%	4,099
18	ALNY	Alnylam Pharmaceuticals, Inc.	1.67%	10,103
19	ROIV	Roivant Sciences Ltd.	1.65%	60,424
20	NBIX	Neurocrine Biosciences, Inc.	1.57%	11,651
21	BBIO	BridgeBio Pharma, Inc.	1.55%	23,936
22	JAZZ	Jazz Pharmaceuticals plc	1.54%	7,575
23	ARGX	argenx SE	1.41%	2,055
24	BMRN	BioMarin Pharmaceutical Inc.	1.35%	27,920
25	EXEL	Exelixis, Inc.	1.35%	31,534

Showing 25 of 72 holdings

Subscribe to see the full list

Activate Now

As of Jul 31, 2026